ALSPIRON

Medicinal product

(Invented) name

ALSPIRON

Active substance (s)

Spironolaktonas

Strength

25 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

C03DA01, Spironolactone

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2025-04-25

Date of renewal

Documents

2517_2518_ALSPIRON_25_50mg_PL.docx

2517_ALSPIRON_25 mg_N20_PZ.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Spironolaktonas	25 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
117409	103514	1103514	lizdinė plokštelė	N20		Receptinis	LT/L/25/2517/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2025-04-25	Registruotas